MedPath

MethylPREDNISolone

Methylprednisolone Tablets USP

Approved
Approval ID

a14c4f76-6dd5-4c84-b6e5-e5abf19ab559

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 22, 2023

Manufacturers
FDA

PD-Rx Pharmaceuticals, Inc.

DUNS: 156893695

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

methylprednisolone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55289-649
Application NumberANDA040183
Product Classification
M
Marketing Category
C73584
G
Generic Name
methylprednisolone
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 22, 2023
FDA Product Classification

INGREDIENTS (4)

METHYLPREDNISOLONEActive
Quantity: 4 mg in 1 1
Code: X4W7ZR7023
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MethylPREDNISolone - FDA Drug Approval Details